NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) was upgraded by BMO Capital Markets to a “strong-buy” rating in a report released on Monday,Zacks.com reports. A number of other research firms have also recently weighed in on NAMS. Jefferies Financial Group restated a “buy” rating and issued a $45.00 price target on shares of NewAmsterdam Pharma […]

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) was upgraded by investment analysts at BMO Capital Markets to a “strong-buy” rating in a research report issued to clients and investors on Monday,Zacks.com reports. Other research analysts also recently issued reports about the company. Wall Street Zen upgraded NewAmsterdam Pharma from a “sell” rating to a “hold” […]

Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) was upgraded by research analysts at BMO Capital Markets to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports. Several other equities research analysts also recently weighed in on TRVI. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Trevi Therapeutics in a report on […]

Stryker (NYSE:SYK – Get Free Report) was upgraded by research analysts at BMO Capital Markets to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. A number of other analysts have also recently issued reports on the company. Sanford C. Bernstein set a $410.00 target price on Stryker in a report on Friday, May […]